A new study examines the role of the GSK3β—cyclin D3—CUGBP1 pathway in the pathogenesis of DM1 and its potential as a therapeutic target.
News
01/07/2018 - 3:29pm
Development of a mini gene tool facilitates the identification of candidate therapeutics targeted at dissociating MBNL from expanded CUG repeats.
12/11/2017 - 2:06pm
Increased skin cancer risks in DM1 are captured in a new, longitudinal electronic medical records study.
12/11/2017 - 2:00pm
A recent publication suggests that a serum protein may ultimately have value as a biomarker for conduction system abnormalities in DM.
11/13/2017 - 11:36am
CRISPR is an exploratory strategy with potential for treatment of RNA-triggered diseases. Will DNA or RNA targeting prove to be the best approach for DM?
